NYSE · Health Care

Centene Corporation CNC

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.

Medical Specialities

Company profile

Business mix

  • It operates through four segments: Medicaid, Medicare, Commercial, and Other.
  • This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.
  • The Commercial segment provides health insurance marketplace product for individual and commercial group.
  • The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within healthcare plans?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 3 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE N/A FCF 23.11% Buyback 4.21%
2026-06-07

Current firm holders

Firm Weight Value Filing period
Oakmark / Harris Associates Bill Nygren 0.6% $461.5M 2026-03-31
Glenview Capital Management Larry Robbins 2.6% $105.2M 2026-03-31
Lyrical Asset Management 1.3% $82.9M 2026-03-31

Recent trading changes over the last 2 quarters

Net buyers 2 Last 2 13F filing periods
Net reducers 3 Last 2 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $255.6M Estimated from net added shares
Reduction amount $23.8M Estimated from net reduced shares
Net share change / base shares +50.2% +7,127,962 / 14,211,782
Gotham Asset Management Joel Greenblatt 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Minor reduction Shares -8.9% 13F value change +$1.7M
13F 2026-03-31 Filed 2026-05-15
Minor reduction Shares -4.0% 13F value change -$8.3M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 941,206 Last 2 periods -118,596 (-12.6%) Total shares 822,610 Value $26.9M
Oakmark / Harris Associates Bill Nygren 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Minor reduction Shares -0.8% 13F value change +$46.7M
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 55.7% 13F value change +$89.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 9,127,944 Last 2 periods +4,966,587 (+54.4%) Total shares 14,094,531 Value $461.5M
Glenview Capital Management Larry Robbins 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Major increase Shares 398.9% 13F value change +$63.1M
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 73.2% 13F value change +$28.8M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 371,972 Last 2 periods +2,841,674 (+763.9%) Total shares 3,213,646 Value $105.2M
Lyrical Asset Management 2 filing periods
13F 2025-12-31 Filed 2026-02-11
Minor reduction Shares -3.9% 13F value change +$9.9M
13F 2026-03-31 Filed 2026-05-11
Minor increase Shares 3.0% 13F value change -$18.3M
Settlement As of 13F 2026-03-31 · Filed 2026-05-11
Base shares 2,560,074 Last 2 periods -27,376 (-1.1%) Total shares 2,532,698 Value $82.9M
Bridgewater Associates Ray Dalio 2 filing periods
13F 2025-06-30 Filed 2025-08-13
Major increase Shares 22.1% 13F value change +$6.7M
13F 2025-09-30 Filed 2025-11-13
Major reduction Shares -54.2% 13F value change -$56.1M
Settlement As of 13F 2025-09-30 · Filed 2025-11-13
Base shares 1,210,586 Last 2 periods -534,327 (-44.1%) Total shares 676,259 Value $24.1M

Recent mentions

No public mentions.